Leukocytapheresis (LCAP) decreases the level of platelet-derived microparticles (MPs) and increases the level of granulocytes-derived MPs: A possible connection with the effect of LCAP on rheumatoid arthritis

Modern Rheumatology

Volumn 19, Issue 3, 2009, Pages 265-272

  Umekita, Kunihiko ^a   Hidaka, Toshihiko ^b   Ueno, Shiro ^a   Takajo, Ichiro ^a   Kai, Yasufumi ^a   Nagatomo, Yasuhiro ^a   Sawaguchi, Akira ^a   Suganuma, Tatsuo ^a   Okayama, Akihiko ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b Zenjinkai Shimin no Mori Hospital   (Japan)

Author keywords

Disease activity; Leukocytapheresis; Microparticles; Rheumatoid arthritis

Indexed keywords

ANTIGEN; BUCILLAMINE; CD16 ANTIGEN; CD42A ANTIGEN; CD61 ANTIGEN; CD61B ANTIGEN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE DERIVED MICROPARTICLE; HUMAN; JAPAN; LEUKAPHERESIS; LEUKOCYTE MICROPARTICLE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THROMBOCYTE COUNT; ULTRASTRUCTURE;

ADULT; ARTHRITIS, RHEUMATOID; BLOOD PLATELETS; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; HUMANS; INTEGRIN BETA3; LEUKAPHERESIS; MIDDLE AGED; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; TRAUMA SEVERITY INDICES;

EID: 67349274519     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-009-0164-2     Document Type: Article

References (33)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356-61.
2. Pap T, Muller-Ladner U, Gay RE, Gay S. Fibroblast biology role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2000;2:361-7.
3. Tarner IH, Müller-Ladner U, Gay S. Emerging targets of biologic therapies for rheumatoid arthritis. Nat Clin Pract Rheumatol. 2007;3:336-45.
4. Distler JH, Pisetsky DS, Huber LC, Kalden JR, Gay S, Distler O. Microparticles as regulators of inflammation. Novel players of cellular crosstalk in the rheumatic disease. Arthritis Rheum. 2005;52:3337-48.
5. Gasser O, Schifferli JA. Microparticles released by human neutrophils adhere to erythrocytes in the presence of complement. Exp Cell Res. 2005;307:381-7.
6. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: Important and underappreciated mediators of cell-to-cell communication. Leukemia. 2006;20:1487-95.
7. Martinez MC, Tesse A, Zobairi F, Andriantsitohaina R. Shed membrane microparticles from circulating from vascular cells in resulting vascular function. Am J Physiol Heart Circ Physiol. 2005;288:1004-9.
8. Berckmans RJ, Nieuwland R, Tak PP, Boing AN, Romijn FP, Kraan MC, et al. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively vai a factor VII-dependent mechanism. Arthritis Rheum. 2002;46:2857-66.
9. Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MA. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum. 2002;46:1498-503.
10. Hidaka T, Suzuki K, Matsuki Y, Takamizawa-Matsumoto M, Kataharada K, Ishizuka T, et al. Filtration leukocytapheresis therapy in rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 1999;42:431-7.
11. Emmrich J, Petermann S, Nowak D, Beutner I, Brock P, Klingel R, et al. Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis - results of a randomized pilot trial. Dig Dis Sci. 2007;52:2044-53.
12. Ueki Y, Yamasaki S, Kanamoto Y, Kawazu T, Yano M, Matsumoto K, et al. Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis. Rheumatology (Oxford). 2000;39:165-71.
13. Eguchi K, Saito K, Kondo M, Hidaka T, Ueki Y, Tanaka Y. Enhanced effect of high-dose leukocytapheresis using a large filter in rheumatoid arthritis. Mod Rheumatol. 2007;17:481-5.
14. Hidaka T, Suzuki K. The mechanism of the efficiency of leukocytapheresis on rheumatoid arthritis. Ther Apher. 1997;1:215-8.
15. Hidaka T, Suzuki K, Matsuki Y, Takamizawa-Matsumoto M, Okada M, Ishizuka T, et al. Changes in CD4+ T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. Ther Apher. 1999;3:178-85.
16. Ueki Y, Nakamura H, Kanamoto Y, Miyazaki M, Yano M, Matsumoto K, et al. Comparison of lymphocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheumatoid arthritis. Ther Apher. 2001;5:455-61.
17. Hidaka T, Suzuki K, Kawakami M, Okada M, Kataharada K, Shinohara T, et al. Dynamic changes in cytokine levels in serum and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. J Clin Apher. 2001;16:74-81.
18. Andoh A, Ogawa A, Kitamura K, Inatomi O, Fujino S, Tsujikawa T, et al. Suppression of interleukin-1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis. J Gastroenterol. 2004;39:1150-7.
19. Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Kikuyama M, et al. Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis. World J Gastroenterol. 2005;11:3085-90.
20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24.
21. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include 28-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44-8.
22. Jy W, Horstman LL, Jimenez JJ, Ahn YS, Biro E, Nieuwland R, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost. 2004;2:1842-51.
23. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: Linking hemostasis and inflammation. Blood Rev. 2007;21:99-111.
24. Bergmeier W, Chauhan AK, Wagner DD. Glycoprotein Ibalpha and von Willebrand factor in primary platelet adhesion and thrombus formation: lessons from mutant mice. Thromb Haemost. 2008;99:264-70.
25. Hutchinson RM, Davis P, Jayson MI. Thrombocytosis in rheumatoid arthritis. Ann Rheum Dis. 1976;35:138-42.
26. Farr M, Scott DL, Constable TJ, Hawker RJ, Hawkins CF, Stuart J. Thrombocytosis of active rheumatoid disease. Ann Rheum Dis. 1983;42:545-9.
27. Fukunaga K, Fukuda Y, Yokoyama Y, Ohnishi K, Kusaka T, Kosaka T, et al. Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients. J Gastroenterol. 2006;41:524-32.
28. Yagi Y, Andoh A, Inatomi O, Bamba S, Tsujikawa T, Fujiyama Y, et al. Modulation of platelet aggregation responses by leukocytapheresis therapy in patients with active ulcerative colitis. J Gastroenterol. 2006;41:540-6.
29. Gasser O, Hess C, Miot S, Deon C, Sanchez JC, Schifferli JA. Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. Exp Cell Res. 2003;285:243-57.
30. Hirayama A, Nagase S, Ueda A, Ishizu T, Taru Y, Yoh K, et al. Oxidative stress during leukocyte absorption apheresis. J Clin Apher. 2003;18:61-6.
31. Daniel L, Fakhouri F, Joly D, Mouthon L, Nusbaum P, Grunfeld JP, et al. Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int. 2006;69:1416-23.
32. Gasser O, Schifferli JA. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood. 2004;104:2543-8.
33. Hoffmann PR, de Cathelineau AM, Ogden CA, Leverrier Y, Bratton DL, Daleke DL, et al. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol. 2001;155:649-59.